SG11201805846TA - Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound - Google Patents

Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound

Info

Publication number
SG11201805846TA
SG11201805846TA SG11201805846TA SG11201805846TA SG11201805846TA SG 11201805846T A SG11201805846T A SG 11201805846TA SG 11201805846T A SG11201805846T A SG 11201805846TA SG 11201805846T A SG11201805846T A SG 11201805846TA SG 11201805846T A SG11201805846T A SG 11201805846TA
Authority
SG
Singapore
Prior art keywords
cells
hepatic
molecular
low
weight compound
Prior art date
Application number
SG11201805846TA
Inventor
Takahiro Ochiya
Takeshi Katsuda
Original Assignee
Nat Cancer Center Japan
Cynity Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Cancer Center Japan, Cynity Co Ltd filed Critical Nat Cancer Center Japan
Publication of SG11201805846TA publication Critical patent/SG11201805846TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases (EC 2.)
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/04—Screening or testing on artificial tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)

Abstract

The present invention provides a method for producing hepatic stem/progenitor cells from mammal hepatocytes, comprising bringing a TGFI-receptor inhibitor, and optionally a GSK3 inhibitor and/or a ROCK inhibitor into contact with the hepatocytes in vitro. 36
SG11201805846TA 2016-01-08 2017-01-06 Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound SG11201805846TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016003088 2016-01-08
PCT/JP2017/000342 WO2017119512A1 (en) 2016-01-08 2017-01-06 Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound

Publications (1)

Publication Number Publication Date
SG11201805846TA true SG11201805846TA (en) 2018-08-30

Family

ID=59273713

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201805846TA SG11201805846TA (en) 2016-01-08 2017-01-06 Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound
SG10202006104YA SG10202006104YA (en) 2016-01-08 2017-01-06 Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10202006104YA SG10202006104YA (en) 2016-01-08 2017-01-06 Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound

Country Status (13)

Country Link
US (1) US10961507B2 (en)
EP (1) EP3401392B1 (en)
JP (1) JP7063624B2 (en)
KR (1) KR20180114032A (en)
CN (1) CN108779439B (en)
AU (1) AU2017205801A1 (en)
CA (1) CA3010808A1 (en)
DK (1) DK3401392T3 (en)
ES (1) ES2908707T3 (en)
PL (1) PL3401392T3 (en)
RU (1) RU2018128598A (en)
SG (2) SG11201805846TA (en)
WO (1) WO2017119512A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190302100A1 (en) * 2016-10-28 2019-10-03 National Cancer Center Method for preparing liver progenitor cells
WO2018097127A1 (en) * 2016-11-22 2018-05-31 国立大学法人京都大学 Method for stepwise induction from hepatoblasts into biliary epithelial progenitor cells
CA3116184A1 (en) * 2018-10-15 2020-04-23 Cynity Co., Ltd. Method for producing stem/precursor cells, by using low molecular weight compound, from cells derived from endodermal tissue or organ
JP7284985B2 (en) * 2019-03-29 2023-06-01 国立大学法人 長崎大学 Method for producing cell population containing hepatic progenitor cells
CN110013544B (en) * 2019-04-23 2021-04-30 中国人民解放军第二军医大学 Application of small molecule combination in preparing medicine for treating chronic liver injury
EP4379045A1 (en) 2021-07-29 2024-06-05 Tokyo Medical University Method for producing highly proliferative cell, and highly proliferative cell and use thereof
KR20240099268A (en) 2021-10-18 2024-06-28 에비아 라이프 사이언시스 인코포레이션 Composition and method of use in the treatment of liver fibrosis
AU2022369459A1 (en) 2021-10-22 2024-05-30 Evia Life Sciences Inc. Methods for making extracellular vesicles, and compositions and methods of use thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08163996A (en) * 1994-12-13 1996-06-25 Sumitomo Bakelite Co Ltd Testing method of toxicity of animal tissue
JPH08308562A (en) * 1995-05-16 1996-11-26 Sumitomo Bakelite Co Ltd Animal cell incubator and measurement of metabolic activity of medicine using the same
JP2000189189A (en) * 1998-12-24 2000-07-11 Jms Co Ltd Method and apparatus for evaluation test using cell
JP2004198150A (en) * 2002-12-17 2004-07-15 Banyu Pharmaceut Co Ltd Method for estimating hepatic metabolic speed of medical substance and method for estimating interaction of medical substance
JP2006254896A (en) * 2005-01-07 2006-09-28 Effector Cell Institute Inc Human hepatocyte-like cell and uses thereof
PL1969118T5 (en) * 2005-12-21 2015-06-30 Univ Catholique Louvain Isolated liver stem cells
CA2634909A1 (en) * 2005-12-22 2007-07-05 Vesta Therapeutics, Inc. Method of using hepatic progenitors in treating liver dysfunction
WO2009117439A2 (en) * 2008-03-17 2009-09-24 The Scripps Research Institute Combined chemical and genetic approaches for generation of induced pluripotent stem cells
US20120021519A1 (en) 2008-09-19 2012-01-26 Presidents And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
WO2010093655A2 (en) * 2009-02-10 2010-08-19 University Of Dayton Enhanced method for producing stem-like cells from somatic cells
CN102741394B (en) 2009-10-16 2016-05-04 斯克里普斯研究所 The induction of pluripotent cell
JP5812492B2 (en) * 2010-02-03 2015-11-11 国立研究開発法人国立がん研究センター Induced hepatic stem cell, method for producing the same, and application of the cell
CN103380212B (en) * 2010-12-22 2017-04-05 菲特治疗公司 For unicellular sorting and the cell culture platform of enhanced IP SC reprogramming
US20130071931A1 (en) 2011-08-02 2013-03-21 National Cancer Center Process for hepatic differentiation from induced hepatic stem cells, and induced hepatic progenitor cells differentiated thereby
WO2014025046A1 (en) * 2012-08-09 2014-02-13 独立行政法人国立がん研究センター Promoter of differentiation from hepatic progenitor cell into hepatic cell, and use thereof
JP6113999B2 (en) * 2012-10-18 2017-04-12 株式会社クラレ Compound screening method
WO2014083132A1 (en) * 2012-11-29 2014-06-05 Cellectis Sa Maturation of hepatocyte-like cells derived from human pluripotent stem cells
WO2014058080A1 (en) 2012-11-30 2014-04-17 独立行政法人理化学研究所 Method for promoting somatic cell reprogramming, and cell preparation kit
AU2014314152B2 (en) 2013-08-28 2020-02-06 Promethera Therapeutics Sa Method for producing adult liver progenitor cells
CN105154386B (en) * 2014-05-30 2018-04-24 中国人民解放军第二军医大学东方肝胆外科医院 Human liver cell maintains for a long time and the special culture media and cultural method of propagation secondary culture

Also Published As

Publication number Publication date
AU2017205801A1 (en) 2018-08-16
JPWO2017119512A1 (en) 2018-11-15
US20190010464A1 (en) 2019-01-10
WO2017119512A1 (en) 2017-07-13
SG10202006104YA (en) 2020-07-29
EP3401392A4 (en) 2019-09-18
JP7063624B2 (en) 2022-05-09
PL3401392T3 (en) 2022-06-27
KR20180114032A (en) 2018-10-17
DK3401392T3 (en) 2022-03-07
ES2908707T3 (en) 2022-05-03
US10961507B2 (en) 2021-03-30
CA3010808A1 (en) 2017-07-13
EP3401392A1 (en) 2018-11-14
CN108779439A (en) 2018-11-09
RU2018128598A (en) 2020-02-11
CN108779439B (en) 2023-05-30
EP3401392B1 (en) 2022-02-23

Similar Documents

Publication Publication Date Title
SG11201805846TA (en) Method for producing hepatic stem/precursor cells from mature hepatic cells using low-molecular-weight compound
USD709551S1 (en) Typeface
IN2013KO01336A (en)
HK1223373A1 (en) A laglidadg homing endonuclease cleaving the c-c chemokine receptor type-5 (ccr5) gene and uses thereof c-c 5(ccr5) laglidadg
SA518390949B1 (en) Method for determining porosity associated with organic matter in a well or formation
MY191035A (en) Affinity-oligonucleotide conjugates and uses thereof
SG10201807292YA (en) Improved reprogramming methods and cell culture platforms
GB2549822B (en) A method of differentiating or promoting the differentiation of NKX6.1/PDX1+pancreatic progenitor cells into non-native pancreatic ß cells in vitro
GB2529099A (en) Hydroentangled Fibrous Structures
SG10201810723VA (en) Improved t cell compositions
MY170162A (en) Bottle with insulative body
EP3943188A3 (en) Design, synthesis and characterization of metal organic frameworks
IN2014DN10053A (en)
USD738429S1 (en) Typeface
AR100050A1 (en) PROCESS FOR ACIDIFICATION USING DELAYED ACID FORMULATIONS
MX2016011006A (en) Device for fabricating spheroid, and spheroid recovery method and manufacturing method.
GB2545583A (en) Stage tool
CL2016000082A1 (en) Cyclodextrins
MY185823A (en) Method of production of gonadotrophin
MX2016003543A (en) Improved fibrous structures containing surfactants and methods for making the same.
AR100224A1 (en) HAMMER FOR MATERIAL REDUCING MACHINES
IN2014DE00026A (en)
USD722900S1 (en) Metal hardness tester block having an alphanumeric platted grid
MX2017007492A (en) Prevention and treatment of inflammatory conditions.
EP3508446A4 (en) Carbon-based hydrogen storage material having autocatalytic capability, production method therefor, and hydrogen adsorbing-storing method, hydrogen releasing method, and hydrogen adsorption-storage device using said compound